Company news
AbCellera Biologics Inc. news in 2024
AbCellera Biologics Inc.'s news releases, calls and decks from 2024, newest first.
AbCellera to Present at Upcoming Investor Conferences in December and January
November 20, 2024
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
November 6, 2024
AbCellera Reports Q3 2024 Business Results
November 3, 2024
AbCellera to Present at Upcoming Investor Conferences in November 2024
October 21, 2024
AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
October 3, 2024
AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
September 25, 2024
AbCellera to Present at Upcoming Investor Conferences in September
August 28, 2024
AbCellera Reports Q2 2024 Business Results
August 5, 2024
AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines
July 30, 2024
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
June 24, 2024
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
May 27, 2024
AbCellera Reports Q1 2024 Business Results
May 6, 2024
AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
April 30, 2024
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
April 7, 2024
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
April 2, 2024
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
March 18, 2024
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
March 10, 2024
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
March 4, 2024
AbCellera Announces Resignation of Board Member
February 22, 2024
AbCellera to Present at Upcoming Investor Conferences in March
February 21, 2024
AbCellera Reports Full Year 2023 Business Results
February 19, 2024
AbCellera to Report Full Year 2023 Financial Results on February 20, 2024
January 22, 2024
Calls in 2024
- AbCellera Biologics (NASDAQ:ABCL) Q3 2024 Earnings Call
Nov 4, 2024
Transcript - AbCellera Biologics (NASDAQ:ABCL) Q2 2024 Earnings Call
Aug 6, 2024
Transcript - AbCellera Biologics (NASDAQ:ABCL) Q1 2024 Earnings Call
May 7, 2024
Transcript - AbCellera Biologics (NASDAQ:ABCL) Q4 2023 Earnings Call
Feb 20, 2024
Transcript
Decks in 2024
- Jefferies London Healthcare Conference 2024
Conference · 11 slides · Nov 19, 2024
- Q3 2024 Earnings Presentation
Earnings · 10 slides · Nov 4, 2024
- Q2 2024 Earnings Presentation
Earnings · 15 slides · Aug 6, 2024
- Q1 2024 Earnings Presentation
Earnings · 14 slides · May 7, 2024
- Investor Presentation (April 2024)
Investor deck · 14 slides · April 2024
- FY2023 Earnings Presentation
Earnings · 22 slides · Feb 20, 2024
- 42nd Annual J.P. Morgan Healthcare Conference 2024
Conference · 14 slides · Jan 10, 2024